These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 5075930)
1. Combined thrombolytic and Dotter treatment in arterial occlusive disease. Eie H; Ro J; Amundsen E; Osvik K J Oslo City Hosp; 1972; 22(9):141-8. PubMed ID: 5075930 [No Abstract] [Full Text] [Related]
2. Relief of chronic peripheral artery obstruction by intravenous Brinase. Frisch EP; Fitzgerald DE J Ir Med Assoc; 1973 Jun; 66(12):313-8. PubMed ID: 4721370 [No Abstract] [Full Text] [Related]
3. [Thrombolytic treatment of arterial occlusions with brinase, a proteolytic enzyme produced by aspergillus]. Numan D; Da Silva MA; Wikner LK; Duckert F Schweiz Med Wochenschr; 1974 Dec; 104(50):1865-7. PubMed ID: 4445859 [No Abstract] [Full Text] [Related]
4. Thrombolytic properties and side effects of brinase (fibrinolytic enzyme from Aspergillus oryzae) in the dog. Roschlau WH J Clin Pathol; 1972 Jul; 25(7):635-6. PubMed ID: 5070267 [No Abstract] [Full Text] [Related]
5. New approach to thrombolytic therapy: the use of Defibrase in connection with streptokinase. Latallo ZS; Lopaciuk S Thromb Diath Haemorrh Suppl; 1973; 56():253-64. PubMed ID: 4617332 [No Abstract] [Full Text] [Related]
7. [Discontinuation of oral anticoagulant therapy following fibrinolytic treatment in arterial occlusive disease]. Engelken HJ; Martin M Med Welt; 1974 Jun; 25(25):1122-4. PubMed ID: 4418430 [No Abstract] [Full Text] [Related]
8. [Results of catheter therapy (Dotter technic) in arterial occlusions of the lower extremity]. Zeitler E; Schoop W; Schmidtke I; Henninges D; Rotter A Verh Dtsch Ges Inn Med; 1972; 78():631-5. PubMed ID: 4665710 [No Abstract] [Full Text] [Related]
9. Comparison of the effect of intra-arterial versus intravenous heparin on radial artery occlusion after transradial catheterization. Pancholy SB Am J Cardiol; 2009 Oct; 104(8):1083-5. PubMed ID: 19801029 [TBL] [Abstract][Full Text] [Related]
10. Prevention of acute experimental arterial thrombosis by defibrination. Haimov M; Danese C Vasc Surg; 1973; 7(4):206-12. PubMed ID: 4762281 [No Abstract] [Full Text] [Related]
11. [Clinical use of thrombolytic agents]. Laprevote-Heully MC; Lambert H; Larcan A Agressologie; 1983 Nov; 24(11):559-65. PubMed ID: 6367511 [No Abstract] [Full Text] [Related]
12. [Results of special treatment methods of ischemic tissue lesions. Stage IV of arterial occlusive disease]. Rieger H; Reinecke B Internist (Berl); 1984 Jul; 25(7):434-8. PubMed ID: 6236162 [No Abstract] [Full Text] [Related]
13. [Use of thrombolytic agents in arterial diseases]. Fiessinger JN; Aiach M Agressologie; 1983 Nov; 24(11):573-7. PubMed ID: 6230946 [No Abstract] [Full Text] [Related]
15. Thrombolytic therapy--a new realistic approach in treatment of thromboocclusive vascular disease. Bell WR Surgery; 1982 Nov; 92(5):913-4. PubMed ID: 7135213 [No Abstract] [Full Text] [Related]
16. [Medical treatment of arteriopathies of the lower extremities]. Juillet Y Soins; 1981 Oct; 26(20):23-8. PubMed ID: 6916466 [No Abstract] [Full Text] [Related]
17. [Percutaneous treatment of arterial occlusive diseases of the limbs using a catheter]. Zeitler E Fortschr Geb Rontgenstr Nuklearmed; 1973; 0(0):suppl:225-6. PubMed ID: 4366626 [No Abstract] [Full Text] [Related]
18. [Antithrombotic therapy and follow-up of peripheral arterial occlusive disease]. Breddin HK Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):633-8. PubMed ID: 10666826 [TBL] [Abstract][Full Text] [Related]